Pfizer Inc _ CSL Animal Health (Pharmaceuticals) [2004] IECompA M04009 (09 February 2004)

Pfizer Inc _ CSL Animal Health (Pharmaceuticals) [2004] IECompA M04009 (09 February 2004)

The Competition Authority found no evidence that the proposed acquisition would substantially lessen competition in the relevant markets.

Citation
[2004] IECompA M04009
Parties
Acquirer: Pfizer Inc.; Target: CSL Animal Health; Parent: CSL Limited
Jurisdiction
Ireland
Judgment Date
09 February 2004
Procedural Posture
Merger Notification / Preliminary Investigation (phase 1)
Outcome
merger cleared
Legal Topics
Merger Control, Pharmaceuticals

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Pfizer Inc.

Acquirer

CSL Animal Health

Target

CSL Limited

Parent

Procedural Posture

Merger Notification / Preliminary Investigation (phase 1)

  1. 1 Whether the proposed acquisition of CSL Animal Health by Pfizer Inc. raises competition concerns under Irish merger control law

Ratio Decidendi

The Competition Authority found no evidence that the proposed acquisition would substantially lessen competition in the relevant markets.

Court Disposition

merger cleared

Orders

  • The proposed acquisition of CSL Animal Health by Pfizer Inc. is approved.